Efficacy Study of p38 Kinase Inhibitor to Treat Patients With Atherosclerosis

NCT00570752 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Vascular Diseases

Interventions

OTHER: Placebo
DRUG: BMS-582949
DRUG: Atorvastatin
DRUG: Statin

Sponsor

Bristol-Myers Squibb